Blue chip 3M Co (NYSE:MMM) is surging, up 15.9% to trade at $119.75 at last check, after the company reported better-than-expected earnings and revenue for the second quarter.
3M Co (NYSE:MMM) shares surged more than 17% as the maker of Scotch, Post-It and Command products posted a second quarter earnings beat and raised its full-year profit guidance. The company now expects full year adjusted earnings per share (EPS) in the range of $7 to $7.30, up from its earlier forecast of $6.80 to $7.30.
3M's NYSE: MMM rebound is gaining momentum because of surprisingly good results. Today's story is that repositioning efforts are taking hold and driving improved profitability while litigation risks dwindle.
3M (MMM) came out with quarterly earnings of $1.93 per share, beating the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $2.17 per share a year ago.
Shares of 3M Co. MMM, +0.14% charged up 5.3% toward an 20-month high in premarket trading Friday, after the maker of Post-it Notes, Scotch tape and Command strips beat second-quarter earnings expectations and raised its full-year outlook. The earnings report is the first that doesn't include 3M's healthcare business, which was spun off as Solventum Corp. SOLV, -0.93% on April 1.
3M Company MMM will release its financial results for the second quarter, before the opening bell on Friday, July 26.
The company reports second-quarter earnings on Friday. Wall Street is looking for earnings per share of $1.68 from sales of $5.9 billion.
3M Co MMM will report second-quarter earnings on Friday, July 25. Wall Street expects $1.68 in EPS and $5.9 billion in revenues as the company reports before market hours.
As 3M (MMM) gears up to report second-quarter earnings, let us find out how the expectations stack up and whether it is the right time to buy the stock.
Industrial giant 3M has been buffeted by legal and regulatory issues. The company's legal problems got so bad that management needed to spin off its crown jewel medical assets to raise capital.
3M investors who ignored MMM's peak pessimism have performed remarkably. MMM has consolidated well along the $100 level. Selling enthusiasm has also been lacking. 3M's new leadership team must execute well in the second half to meet its FY2024 guidance promulgated previously.
3M (MMM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.